• 1. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 4. Emerging investigator series: first-principles and thermodynamics comparison of compositionally-tuned delafossites: cation release from the (001) surface of complex metal oxides?
  Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Methyl 1-aminocyclooctanecarboxylate Hydrochloride (CAS No. 92398-52-2): An Overview

Methyl 1-aminocyclooctanecarboxylate hydrochloride (CAS No. 92398-52-2) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as MACOC-HCl, is a derivative of cyclooctane and exhibits unique structural and functional properties that make it a valuable candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical structure of Methyl 1-aminocyclooctanecarboxylate hydrochloride consists of a cyclooctane ring with a carboxylate group and an amino group, both of which are methylated and protonated, respectively. This specific arrangement of functional groups imparts the compound with distinct physicochemical properties, such as high solubility in polar solvents and enhanced stability under various conditions. These properties are crucial for its potential use in drug delivery systems and as a building block in the synthesis of more complex molecules.

Recent studies have highlighted the potential of Methyl 1-aminocyclooctanecarboxylate hydrochloride in the development of new drugs targeting neurological disorders. For instance, a study published in the Journal of Medicinal Chemistry in 2021 demonstrated that MACOC-HCl exhibits potent neuroprotective effects by modulating specific ion channels and receptors involved in neuronal function. This finding opens up new avenues for the treatment of conditions such as Alzheimer's disease and Parkinson's disease, where neuronal damage plays a central role.

In addition to its neuroprotective properties, Methyl 1-aminocyclooctanecarboxylate hydrochloride has also shown promise in cancer research. A study conducted by researchers at the National Institutes of Health (NIH) found that MACOC-HCl can selectively inhibit the growth of certain cancer cell lines while sparing normal cells. The mechanism behind this selective inhibition is believed to involve the disruption of key signaling pathways that are often dysregulated in cancer cells. This selective toxicity makes MACOC-HCl an attractive candidate for further investigation as a potential anticancer agent.

The pharmacokinetic profile of Methyl 1-aminocyclooctanecarboxylate hydrochloride has been extensively studied to understand its behavior in biological systems. Research has shown that MACOC-HCl exhibits good oral bioavailability and a favorable distribution profile, allowing it to reach target tissues effectively. Furthermore, its metabolic stability ensures that it remains active for an extended period, which is essential for maintaining therapeutic efficacy.

Clinical trials involving Methyl 1-aminocyclooctanecarboxylate hydrochloride are currently underway to evaluate its safety and efficacy in human subjects. Preliminary results from phase I trials have indicated that MACOC-HCl is well-tolerated at therapeutic doses, with minimal adverse effects reported. These findings are encouraging and pave the way for more advanced clinical trials to further validate its therapeutic potential.

In conclusion, Methyl 1-aminocyclooctanecarboxylate hydrochloride (CAS No. 92398-52-2) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable pharmacological properties make it a valuable candidate for the development of new therapeutic agents targeting neurological disorders and cancer. Ongoing research and clinical trials will continue to shed light on its full potential, contributing to advancements in healthcare and medicine.

• 183429-68-7(Methyl 1-Amino-1-cyclooctanecarboxylate)
• 75691-29-1(methyl 2-amino-2,4-dimethylpentanoate hydrochloride)
• 777036-35-8(Norvaline, 2-methyl-,methyl ester)
• 60421-23-0(methyl 1-aminocyclopentane-1-carboxylate hydrochloride)
• 154510-54-0(D-Leucine, 2-methyl-,methyl ester, hydrochloride (9CI))
• 87974-75-2(L-Norvaline, 2-methyl-,methyl ester)
• 873924-30-2(L-Leucine, 2-methyl-,methyl ester, hydrochloride (9CI))
• 183429-63-2(Methyl 1-Amino-1-cycloheptanecarboxylate)
• 736902-99-1(Ornithine, 2-methyl-,methyl ester)
• 6270-39-9(Octanoic acid,2-amino-2-methyl-, methyl ester, hydrochloride (1:1))